Alzheimer's
Five New Grants Awarded to Study Alzheimer's 
0
© Stephen Cummings
Memory Walk Campaign
Five early-career scientists were awarded The Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease (AD). The $75,000 awards provide a broad array of funding in the biological, genetic, and environmental causes of AD. By studying the early changes suggesting Alzheimer's disease from different but complementary angles, the awards seek to accelerate development of diagnostic, preventative interventions, and treatments.
Continue reading Five New Grants Awarded to Study Alzheimer's.
H1N1
First H1N1 Vaccines Will be Nasal Spray 0
The first U.S. roll-out of vaccines against the new swine flu virus will be 3.4 million doses of MedImmune's nose spray, the Centers for Disease Control and Prevention said on Friday.
Technology
TCT 2009 to Address Electronic Health Records 0
In addition to breaking news and new research data from clinical trials, investigations and registries, TCT (Transcatheter Cardiovascular Therapeutics) 2009, the largest global medical and scientific symposium dedicated to interventional cardiovascular medicine, will feature an important discussion led by national experts on Electronic Health Records (EHR).
The Wire - News Headlines
Combined News
Bioethics, Biotech Policy, regulation and Legal Issues
Biotech Manufacturing and Processing
Bioterrorism and Biodefense
Bird Flu
Cloning, Stem Cells and Regenrative Medicine
Food and Agriculture
Genetic Engineering
Genomics and Bioinformatics
Health, Emerging and Recurring Disease
Nanotechnology
Press Releases
Vaccines and Therapeutics
Featured Stories
Biotech Policy
How Biotech Legislation Plays Back Home
Lawmakers reaped health lobby dollars, The News & Observer
Drug makers, insurance companies and health providers have chosen carefully in deciding where to put their campaign dollars in North Carolina. North Carolina's lawmakers in Washington have received millions of dollars from health-related companies in the past three campaigns, according to a new analysis by Democracy North Carolina, a government watchdog group.
Cancer
Breakthrough Holds Promise for Development of Effective Cancer Therapies
Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies.
Health News
New Research Predicts Who Will Respond to Hepatisis C Treatment
In a paper title Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance published online in the Journal Nature researches report that they have identified a gene that predicts a response to treatment for Hepatitis C.
Health Outreach
A Hospital without Walls
At Virginia Hospital Center, treating disease doesn't require a patient-or a room.
When Cathy Turner looked at the blood sugar readings she had just taken, she was shocked. It read over 400, four times the average fasting level. She told the woman, an employee of an Arlington Virginia business she was visiting, that the test results called for a trip to her doctor.